Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran

Conclusions: In addition to clinical and preclinical studies, our cases add to the experience regarding the safety and efficacy of idarucizumab. They show that idarucizumab may be an important safety option for patients on dabigatran in emergency situations.Case Rep Neurol 2016;8:224 –228
Source: Case Reports in Neurology - Category: Neurology Source Type: research